Clinical Trials Directory

Trials / Completed

CompletedNCT03461523

Observational, Prospective, Single-center Study: Should Body Mass Index (BMI) be Added to the Scoring Criteria of Hepatic Critically Ill Patients in Intensive Care Unit??

Status
Completed
Phase
Study type
Observational
Enrollment
517 (actual)
Sponsor
National Hepatology & Tropical Medicine Research Institute · Other Government
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to evaluate the hypothesis of poor clinical outcomes in critically ill patients that are having abnormal BMI.

Detailed description

All demographic data will be obtained including the patients' age, sex, body mass index (BMI) \& categorized into; BMI \< 18.5Kg/m2 = underweight, BMI between 18.5-24.9Kg/m2 = normal weight, while BMI between 25-29.9Kg/m2 = overweight \& obese = BMI ≥ 30Kg/m2, associated co-morbidities (diabetes mellitus, hypertension, chronic renal failure, cancer\& chronic liver disease), the cause of admission to ICU, Sequential Organ Failure Assessment (SOFA), nutritional risk screening (NRS) on admission \& discharge, prior cardiac arrest, previous ICU admission within 6months, nosocomial infection, organ failure e.g. cardiovascular, respiratory, renal \& organic support requirement e.g. hemodynamic support, mechanical ventilation, renal replacement therapy (RRT).

Conditions

Timeline

Start date
2018-02-10
Primary completion
2020-06-24
Completion
2021-02-19
First posted
2018-03-12
Last updated
2021-02-21

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03461523. Inclusion in this directory is not an endorsement.